{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "POLITICO.eu"}, "author": "Mari Eccles", "title": "Ozempic cut heavy drinking in clinical study - POLITICO Europe", "description": "The small study suggests there\u2019s promise in further investigating the drug in this field.", "url": "https://www.politico.eu/article/ozempic-cut-heavy-drinking-in-clinical-study-first/", "urlToImage": "https://www.politico.eu/cdn-cgi/image/width=1200,height=630,fit=crop,quality=80,onerror=redirect/wp-content/uploads/2025/02/12/GettyImages-1741637270-scaled.jpg", "publishedAt": "2025-02-12T18:21:00Z", "content": "The U.S. researchers said the results justify larger clinical trials to evaluate this class of drugs known as glucagon-like peptide 1 (GLP-1) receptor agonists for alcohol use disorder. The study is \u2026 [+785 chars]"}]}